Qube Research & Technologies (QRT)
LUNG icon

Qube Research & Technologies (QRT)’s Pulmonx LUNG Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.8K Buy
+49,877
New +$68.7K ﹤0.01% 3090
2024
Q3 		– Sell
-9,919
Closed -$62.9K – 3780
2024
Q2 		$62.9K Sell
9,919
-10,561
-52% -$81.2K ﹤0.01% 2695
2024
Q1 		$190K Buy
20,480
+18,711
+1,058% +$219K ﹤0.01% 3045
2023
Q4 		$22.6K Buy
+1,769
New +$18.4K ﹤0.01% 3464
2022
Q3 		– Sell
-54,651
Closed -$804K – 2793
2022
Q2 		$804K Buy
+54,651
New +$1.13M 0.01% 1192
2021
Q2 		– Sell
-14,185
Closed -$649K – 2583
2021
Q1 		$649K Buy
+14,185
New +$814K 0.01% 1029

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LUNG Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Pulmonx (LUNG) in Q2 2026: 49,877 shares worth $64.8K. The stake represents ﹤0.01% of the portfolio and ranks #3090 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in LUNG as recently as Q2 2024.

Qube Research & Technologies (QRT) first reported a position in LUNG in Q1 2021 and has held it in 6 quarters since. The position peaked at $804K in Q2 2022. 107 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Qube Research & Technologies (QRT) held 49,877 shares of Pulmonx worth $64.8K as of Q2 2026.
  • Pulmonx was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Pulmonx made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3090 holding.
  • Qube Research & Technologies (QRT) first reported a position in Pulmonx in Q1 2021 and has held it in 6 quarters since.
  • Qube Research & Technologies (QRT)'s Pulmonx position peaked at $804K in Q2 2022.
  • 107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.